Patients at risk of rheumatoid arthritis may wonder if there are lifestyle factors that play a role. What are some of the factors that you can discuss with them, and what can you recommend they do?
Researchers assessed perceived COVID-19 risk for infections and outcomes, as well as shielding practices, among patients with rheumatoid arthritis (RA) during the pandemic.
Researchers evaluated the outcomes of COVID-19 in patients with rheumatoid arthritis vs the general population, and also explored the outcomes among patients with RA, stratified by sex, race, and medications.
In a meta-analysis, researchers investigated the effectiveness of exercise therapy on muscle mass gain in patients with rheumatoid arthritis and identified the factors for treatment efficacy in muscle mass gain.
Worse functional status and increased probability of functional decline are seen for patients with rheumatoid arthritis with lower socioeconomic status.
Researchers assessed the dynamical trajectory and features of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis initiating GCs in combination with conventional synthetic DMARDs.
Researchers assessed mortality rates in rheumatoid arthritis-related interstitial lung disease as well as the association between mortality, radiographic patterns, and confounding factors.
An OMERACT 2020 special interest group report was developed to determine the best method to incorporate patient perspectives into rheumatoid arthritis remission criteria.
